StockNews.com Begins Coverage on LifeVantage (NASDAQ:LFVN)

Equities researchers at StockNews.com started coverage on shares of LifeVantage (NASDAQ:LFVNGet Rating) in a research note issued on Monday. The brokerage set a “buy” rating on the stock.

LifeVantage Trading Down 1.8 %

LFVN opened at $3.84 on Monday. The firm has a market cap of $48.20 million, a price-to-earnings ratio of 16.00 and a beta of 1.22. LifeVantage has a 12 month low of $3.59 and a 12 month high of $7.70. The stock has a fifty day moving average price of $4.08 and a 200-day moving average price of $4.36.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Private Advisor Group LLC acquired a new position in LifeVantage during the 2nd quarter valued at about $49,000. Victory Capital Management Inc. increased its position in LifeVantage by 30.4% during the 1st quarter. Victory Capital Management Inc. now owns 13,868 shares of the company’s stock valued at $66,000 after buying an additional 3,235 shares in the last quarter. Campbell & CO Investment Adviser LLC increased its position in LifeVantage by 117.2% during the 1st quarter. Campbell & CO Investment Adviser LLC now owns 21,717 shares of the company’s stock valued at $103,000 after buying an additional 11,717 shares in the last quarter. O Shaughnessy Asset Management LLC increased its position in LifeVantage by 49.8% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 23,461 shares of the company’s stock valued at $148,000 after buying an additional 7,804 shares in the last quarter. Finally, American Century Companies Inc. increased its position in LifeVantage by 30.3% during the 1st quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock valued at $219,000 after buying an additional 10,706 shares in the last quarter. 27.06% of the stock is owned by institutional investors and hedge funds.

About LifeVantage

(Get Rating)

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Featured Stories

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.